A grieving mother from Michigan has turned to Canada for what she calls a life-saving vaccine that isn’t available in the U.S.
Alicia Stillman believes that had her daughter Emily been vaccinated for meningitis B, she would still be alive.
Meningitis B killed 19-year-old Emily Stillman in February 2013. The Kalamazoo College student died within 36 hours of arriving at a hospital with a severe headache, Stillman said.
Since Emily’s death, a meningitis B vaccine, Bexsero by Novartis, has been given approval in Canada. At the time of her death, it was available in Australia and Europe.